Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : MHV370
CAS No.: 2205095-75-4
Catalog No.: PC-20815Not For Human Use, Lab Use Only.
MHV370 (MHV-370) is a potent, selective, orally bioavailable inhibitor of Toll-like receptors 7 and 8 (TLR7/8) with IC50 of 1.1 and 4.5 nM in cell-based assays.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $398 | In stock | |
| 10 mg | $598 | In stock | |
| 25 mg | Get quote | ||
| 50 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MHV370 (MHV-370) is a potent, selective, orally bioavailable inhibitor of Toll-like receptors 7 and 8 (TLR7/8) with IC50 of 1.1 and 4.5 nM in cell-based assays.
MHV370 potently inhibited CL307- and R848-driven reporter gene activity in cells with IC50 of 15 nM and 7 nM, respectively.
MHV370 displayed no activity against other TLRs (TLR1/2, TLR2/6), tumor necrosis factor (TNF) receptor, and NOD1 at 10 uM.
MHV370 did not lead to cell toxicity at 10 uM, did not block ODN2216/TLR9-dependent IFN-α secretion from isolated human pDCs.
MHV370 potently suppressed production of multiple cytokines following activation of isolated monocytes with the TLR8-specific agonist TL8-0506, i.e., TNF, interleukin-6 (IL-6), and IL-1β.
MHV370 inhibited ssRNA-induced IFN-α and TNF responses on PBMCs with IC50 of 4.1 and 70 nM, respectively.
MHV370 is a potent, selective, and reversible antagonist of TLR7 and TLR8 in humans, and a selective TLR7 antagonist in mice.
MHV370 blocks activation of cell types that drive lupus, including B cells and pDCs.
MHV370 (5 mg, oral) suppresses acute TLR7-dependent immune activation in mice.
MHV370 suppresses ISGs in the TMPD peritonitis model, protects from lupus-like disease in the NZB/W F1 mouse model.
| M.Wt | 532.69 | |
| Formula | C29H40N8O2 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
(S)-N-(4-((5-(1,6-dimethyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-3-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-1-yl)methyl)bicyclo[2.2.2]octan-1-yl)morpholine-3-carboxamide |
|
1. Phil B Alper, et al. Bioorg Med Chem Lett. 2020 Sep 1;30(17):127366.
2. Stuart Hawtin, et al. Cell Rep Med. 2023 May 16;4(5):101036.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
